November 6, 2023 /

AGAMREE Approval: What this means for you and your family

PPMD was recently joined by Dr. Aravindhan Veerapandiyan of Arkansas Children’s Hospital to discuss the FDA’s recent approval of AGAMREE (vamorolone), a new steroid approved for the treatment of Duchenne muscular dystrophy in individuals aged 2 years and older.

Posted on November 6, 2023

Join Our Mailing List